Home/Filings/4/0001209191-23-056804
4//SEC Filing

Nichols William Garrett 4

Accession 0001209191-23-056804

CIK 0001841387other

Filed

Nov 27, 7:00 PM ET

Accepted

Nov 28, 4:30 PM ET

Size

5.3 KB

Accession

0001209191-23-056804

Insider Transaction Report

Form 4
Period: 2023-11-26
Nichols Garrett
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2023-11-26+88,822147,301 total
Footnotes (1)
  • [F1]Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. 50% of the RSUs shall vest on June 30, 2024, and the remaining 50% on December 31, 2024, in each case subject to the Reporting Person's continued service on such vesting date.

Issuer

Candel Therapeutics, Inc.

CIK 0001841387

Entity typeother

Related Parties

1
  • filerCIK 0001618364

Filing Metadata

Form type
4
Filed
Nov 27, 7:00 PM ET
Accepted
Nov 28, 4:30 PM ET
Size
5.3 KB